Réaction #744081

ord-d61157bbbab54c8aa76a7675d12c5103

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    ExtractionThe reaction was then extracted with 20% MeOH in DCM (3×200 ml)
  2. 2
    AutreThe combined organic phases were dried
  3. 3
    Autreevaporated
  4. 4
    Autrethe crude residue purified by chromatography on silica gel using a 0-20% MeOH/DCM gradient

Mode opératoire

A mixture of 1-[2-(4-amino-1-piperidinyl)ethyl]-7-(methyloxy)-1,5-naphthyridin-2(1H)-one dihydrochloride (164 mg, 0.440 mmol) in chloroform (5 ml) and MeOH (0.5 ml) was treated with triethylamine (194 μl, 1.40 mmol) and stirred for 0.25 h before addition of 3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine-6-carboxaldehyde (for a synthesis see WO2003087098, Example 31(e)) (71 mg, 0.40 mmol). The reaction was stirred for 0.5 h before addition of NaBH(OAc)3 (254 mg, 1.20 mmol). The reaction was stirred for a further 0.5 h before addition of sat. aq NaHCO3 (20 ml). The reaction was then extracted with 20% MeOH in DCM (3×200 ml). The combined organic phases were dried, evaporated and the crude residue purified by chromatography on silica gel using a 0-20% MeOH/DCM gradient to provide the free base of the title compound (144 mg, 71%).

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US08071592B2uspto-grants-2011_12